McKesson sells 13% of Medical‑Surgical Solutions to Apollo Funds in $1.25 B deal

McKesson sells 13% of Medical‑Surgical Solutions to Apollo Funds in $1.25 B deal, marking the largest minority‑stake transaction in the company’s recent carve‑out strategy and setting a new benchmark for financing in the health‑care supply‑chain sector.

Deal Overview

McKesson Corporation (NYSE: MCK) announced a definitive agreement with funds managed by affiliates of Apollo Global Management. Under the terms, Apollo will inject $1.25 billion of convertible preferred equity into McKesson’s Medical‑Surgical Solutions (MMS) business, securing roughly a 13 % ownership stake. The transaction values MMS at about $13 billion on an enterprise basis. While Apollo gains a strategic foothold, McKesson retains operational control and majority ownership, positioning the unit for a planned initial public offering (IPO) later this year.

Technology and Business Implications

MMS operates a cloud‑native platform that integrates inventory management, digital payments and data analytics services for hospitals, ambulatory surgery centers, and long‑term care facilities. The infusion of capital will accelerate the rollout of advanced analytics powered by Microsoft Azure and Salesforce Health Cloud, as well as expand API‑first capabilities that align with open‑banking standards. By leveraging embedded finance tools—similar to those offered by Amazon Pay and Adobe Experience Cloud—MMS can embed payment processing directly into procurement workflows, reducing transaction friction for non‑acute care providers.

Why the Announcement Matters

The deal arrives at a time when Gartner estimates that 70 % of supply‑chain executives will increase spending on digital platforms by 2025, seeking end‑to‑end visibility and real‑time payment reconciliation. For McKesson, the minority‑stake financing de‑risks the carve‑out while preserving cash flow for other growth initiatives, such as expanding its tele‑health logistics network. For Apollo, the investment provides exposure to a high‑margin, recurring‑revenue business that sits at the intersection of health‑care logistics and fintech.

Competitive Context

MMS now competes more directly with specialized health‑care supply platforms like Cardinal Health’s Integrated Solutions and Amazon Business’s health‑care offering. Those rivals have been bolstering their embedded‑finance capabilities, allowing customers to settle invoices with a single click. McKesson’s partnership with Apollo could enable faster scaling of its own embedded‑finance engine, narrowing the technology gap. IDC projects the embedded‑finance market to surpass $7.5 trillion in annual transaction volume by 2025, underscoring the strategic urgency for supply‑chain players to embed payment functionality.

Implications for Enterprise Marketing Teams

Enterprise marketers at health‑care providers will gain richer data streams from MMS’s enhanced analytics layer. With granular insights into purchase patterns, usage rates, and payment behaviors, marketers can craft hyper‑personalized campaigns that align product promotions with budget cycles. Moreover, the integration of Adobe Experience Manager’s content delivery network will allow MMS to deliver targeted educational content at the point of order, driving cross‑sell opportunities without disrupting the procurement workflow.

Regulatory and Financial Considerations

The transaction remains subject to antitrust clearance and customary closing conditions. Convertible preferred equity gives Apollo downside protection while granting upside participation should the eventual IPO exceed valuation expectations. From an accounting perspective, McKesson will continue to consolidate MMS results, preserving its revenue visibility for investors.

Future Outlook

If the planned IPO proceeds on schedule, MMS could become one of the few publicly listed health‑care supply‑chain platforms, offering a transparent benchmark for embedded‑finance adoption in the sector. The partnership also signals a broader trend: financial investors are increasingly targeting niche, technology‑driven health‑care assets that blend logistics with digital payments.

Market Landscape

The health‑care supply‑chain market is undergoing rapid digitization, driven by the need for real‑time inventory visibility and frictionless payments. According to a recent Forrester study, 62 % of hospitals plan to adopt API‑first procurement platforms within the next 24 months. Simultaneously, the fintech ecosystem is expanding into traditionally non‑digital verticals, with embedded finance solutions projected to capture 30 % of B2B transaction volume by 2026. Companies like Google Cloud and Microsoft are providing the underlying infrastructure that powers these platforms, while Salesforce and Adobe supply the customer‑experience layer. In this context, McKesson’s alliance with Apollo positions MMS to capitalize on both supply‑chain efficiency gains and the monetization opportunities presented by embedded finance.

Top Insights

• Apollo’s $1.25 B infusion values MMS at $13 B, creating a sizable minority‑stake precedent in health‑care logistics.
• MMS’s cloud‑native platform will integrate Microsoft Azure, Salesforce Health Cloud, and Adobe Experience tools to boost embedded‑finance capabilities.
• Gartner predicts 70 % of supply‑chain leaders will increase digital‑platform spend by 2025, highlighting the timing of McKesson’s carve‑out.
• IDC forecasts the embedded‑finance market to exceed $7.5 trillion in annual volume by 2025, underscoring the strategic relevance of payment integration.
• Enterprise marketers will gain richer data for personalized outreach, leveraging Adobe and Salesforce analytics embedded in MMS.

Get in touch with our fintech expert